Dealing with uncertainty in the treatment of Helicobacter pylori

被引:14
作者
Calvet, Xavier [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Sabadell, Inst Salud Carlos III, Dept Med,CIBEREHD,Serv Malalties Digest, Parc Tauli 1, Sabadell 08208, Barcelona, Spain
基金
新加坡国家研究基金会;
关键词
Helicobacter pylori; treatment; uncertainty; CONTAINING QUADRUPLE THERAPY; PROTON PUMP INHIBITORS; TRIPLE THERAPY; STANDARD TRIPLE; RESCUE THERAPY; ERADICATION; INFECTION; METAANALYSIS; BISMUTH; CLARITHROMYCIN;
D O I
10.1177/2040622318758240
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Helicobacter pylori treatment may be viewed as an uncertain situation, where current knowledge is insufficient to provide evidence-based recommendations for all possible scenarios. Evidence suggests that, under uncertainty conditions, a few simple rules of thumb tend to work better than complex algorithms. Overall, five evidence-based rules of thumb are suggested: (1) Use four drugs; (2) Use maximal acid inhibition; (3) Treat for 2 weeks; (4) Do not repeat antibiotics after treatment failure; and (5) If your treatment works locally, keep using it. These simple rules of thumb may help the reader to select the best alternative for a given patient, choosing between the heterogeneous recommendations provided by the many different consensus conferences on H. pylori treatment recently published.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 50 条
  • [41] Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera®) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study
    Rodriguez de Santiago, Enrique
    de Argila de Prados, Carlos Martin
    Marcos Prieto, Hector Miguel
    Jorge Turrion, Miguel Angel
    Barreiro Alonso, Eva
    Flores de Miguel, Alvaro
    de la Coba Ortiz, Cristobal
    Rodriguez Escaja, Carlos
    Perez Alvarez, Gustavo
    Ferre Aracil, Carlos
    Aguilera Castro, Lara
    Garcia de Paredes, Ana Garcia
    Rodriguez Perez, Antonio
    Albillos Martinez, Agustin
    [J]. HELICOBACTER, 2017, 22 (05)
  • [42] Acid-inhibitory effects of vonoprazan 20mg compared with esomeprazole 20mg or rabeprazole 10mg in healthy adult male subjects - a randomised open-label cross-over study
    Sakurai, Y.
    Mori, Y.
    Okamoto, H.
    Nishimura, A.
    Komura, E.
    Araki, T.
    Shiramoto, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (06) : 719 - 730
  • [43] Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection
    Shehata, Mona A. H.
    Talaat, Raghda
    Soliman, Samah
    Elmesseri, Huda
    Soliman, Shaimaa
    Abd-Elsalam, Sherief
    [J]. HELICOBACTER, 2017, 22 (05)
  • [44] Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis
    Song, Zhi-Qiang
    Zhou, Li-Ya
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (19) : 4766 - 4775
  • [45] Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (05) : 506 - 511
  • [46] Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy
    Sugimoto, Mitsushige
    Furuta, Takahisa
    Shirai, Naohito
    Kodaira, Chise
    Nishino, Masafumi
    Ikuma, Mutsuhiro
    Ishizaki, Takashi
    Hishida, Akira
    [J]. HELICOBACTER, 2007, 12 (04) : 317 - 323
  • [47] Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations
    Tay, C. Y.
    Windsor, H. M.
    Thirriot, F.
    Lu, W.
    Conway, C.
    Perkins, T. T.
    Marshall, B. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (11-12) : 1076 - 1083
  • [48] Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection
    Venerito, Marino
    Krieger, Tina
    Ecker, Thomas
    Leandro, Gioacchino
    Malfertheiner, Peter
    [J]. DIGESTION, 2013, 88 (01) : 33 - 45
  • [49] Meta-analysis:: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication
    Villoria, A.
    Garcia, P.
    Calvet, X.
    Gisbert, J. P.
    Vergara, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (07) : 868 - 877
  • [50] Optimum duration of regimens for Helicobacter pylori eradication
    Yuan, Yuhong
    Ford, Alex C.
    Khan, Khurram J.
    Gisbert, Javier P.
    Forman, David
    Leontiadis, Grigorios I.
    Tse, Frances
    Calvet, Xavier
    Fallone, Carlo
    Fischbach, Lori
    Oderda, Giuseppina
    Bazzoli, Franco
    Moayyedi, Paul
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12): : 1 - 205